T1	Participants 122 151	proximal deep vein thrombosis
T2	Participants 259 350	preventing deep vein thrombosis both in general surgery and in high-risk orthopedic surgery
T3	Participants 706 744	patients with proximal vein thrombosis
T4	Participants 989 1024	here were 67 patients in each group
T5	Participants 1346 1410	UFH group (seven of 67) than in the enoxaparin group (one of 67)
